The Polish Society of Clinical Pharmacy was founded in 2020 and has set as its goal the promotion and support of the development of clinical pharmacy in Poland and the association of the community of people interested in this field of science.

EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.

Estonian Society of Hospital Pharmacists (ESHP) is a national society founded in 1995 by practicing hospital pharmacists.

The overall mission of the society is:

• to provide continuing education for and evaluate the professional development of our members.
• to represent hospital pharmacy at national level in the interest of patients and public health and to obtain and maintain a joint pharmaceutical policy.
• to share members’ experiences and problems that can be applied to daily practice in other hospitals.

ESHP’s over 130 members include hospital and clinical pharmacists, community pharmacists and pharmacist assistants and everyday management of the ESHP takes place through monthly meetings between board members.

Pharmacy Management produces National Conferences, Regional Workshops and the Pharmacy Management Academy in all countries of the United Kingdom. It is also accredited as a First Wave Training Provider by the Faculty of the Royal Pharmaceutical Society. It has published a Journal of the same name since 1985 which has focused on the world of the commissioning of medicines and the creation of best practice in the delivery of medicines and pharmacy services. During its thirty year history the company has worked with major pharmaceutical companies to ensure that communication with the NHS reaches the highest standards possible and has provided a myriad of contact and access opportunities with these important customers.
The company receives advice from 80+ experienced NHS pharmacists who ensure that programmes and proposals are thoroughly tested before inception. Additionally, PM Market Access is a division of the company that creates bespoke offerings for companies in relation to their unique and specific communication needs with the NHS.

Pharmacy Management has a partnership agreement with the Medicines Optimisation Innovation Centre (MOIC) of Northern Ireland. The two organisations will work together to communicate and promote the development of medicines optimisation throughout the UK and beyond. Chairman of Pharmacy Management, Ted Butler stated: ‘We are very pleased that Professor Michael Scott and colleagues in Northern Ireland have agreed to become partners with Pharmacy Management to communicate the benefits and best practice examples of medicines optimisation. Pharmacy Management was the first organisation in the UK to develop a national conference for medicines optimisation in November 2012 and we see this partnership as a great opportunity to build on that foundation.’
More information: www.pharman.co.uk/ 

The European Connected Health Alliance is the trusted connector in healthcare; we bring people, organisations, needs and solutions together. We are a Community Interest Company (not-for-profit) registered in Northern Ireland. ECHAlliance exists to facilitate multi-stakeholder connections, to create and strengthen partnerships committed to driving sustainable change, in the quality and efficiency of health and social care.
With over 15,000 connections across Europe, North America and China, we are a powerful international force for change, whose combined knowledge, expertise and connections can speed up progress. We work through our International Network of Permanent Ecosystems, an unparalleled network connecting more than 25 multi-sector Ecosystems, each of which brings together a community of stakeholders interested in developing a joint health agenda, relevant to their respective country or region.

Our primary functions are:

• Promotion of connected health – to provide leadership, education and focus supporting European and global implementation of connected health technologies.
• Development of connected health capabilities – to secure and engage in collaborative R&D.
• Participant and member support – to support the strategic and tactical marketing and business development needs of ECHAlliance members.
• Education – to develop and provide educational opportunities, in support of broad scale deployments connected health.

As part of our drive to achieve these primary functions ECHAlliance developed a range of inter-Ecosystem working groups focusing on priority areas highlighted through the network. Medicines Optimisation was identified as a priority area for many Ecosystems and we launched the Medicines Optimisation Working Group (MOWG) in October 2015.  We are delighted that Professor Michael Scott, Director of the Northern Ireland Health Medicines Optimisation Innovation Centre (MOIC) will Chair this international group. MOWG acts as a forum to test thinking, share best practice and provide advice on developments; we will work with MOIC as part of the network to support combined knowledge and expertise to propel progress.
More information: https://echalliance.com/